TransMedics Group, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
TransMedics Group, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2018 to Q3 2024.
  • TransMedics Group, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.94M, a 53.1% increase year-over-year.
  • TransMedics Group, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $28.2M, a 65.2% increase year-over-year.
  • TransMedics Group, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.8M, a 91.8% increase from 2022.
  • TransMedics Group, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.3M, a 50.1% increase from 2021.
  • TransMedics Group, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $6.88M, a 185% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $28.2M $7.94M +$2.76M +53.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $25.4M $7.64M +$2.69M +54.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $22.7M $6.87M +$2.95M +75.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $19.8M $5.72M +$2.73M +91.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $17.1M $5.19M +$2.48M +91.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $14.6M $4.96M +$2.64M +114% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $11.9M $3.92M +$1.61M +69.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $10.3M $2.99M +$1.01M +50.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $9.32M $2.7M +$731K +37.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $8.58M $2.32M +$508K +28.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $8.08M $2.31M +$1.2M +108% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $6.88M $1.99M +$1.29M +184% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 $5.59M $1.97M +$1.27M +182% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $4.32M $1.81M +$1.18M +187% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $3.14M $1.11M +$727K +189% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $2.41M $698K +$416K +148% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $2M $700K +$405K +137% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $1.59M $631K +$411K +187% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $1.18M $385K +$328K +575% Dec 29, 2019 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $854K $282K +$229K +432% Sep 29, 2019 Dec 28, 2019 10-K 2021-03-11
Q3 2019 $625K $295K +$264K +852% Jun 30, 2019 Sep 28, 2019 10-Q 2020-11-06
Q2 2019 $361K $220K +$187K +567% Mar 31, 2019 Jun 29, 2019 10-Q 2020-08-10
Q1 2019 $174K $57K +$30K +111% Dec 30, 2018 Mar 30, 2019 10-Q 2020-05-06
Q4 2018 $144K $53K Sep 30, 2018 Dec 29, 2018 10-K 2020-03-17
Q3 2018 $31K Jul 1, 2018 Sep 29, 2018 10-Q 2019-11-08
Q2 2018 $33K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $27K Dec 31, 2017 Mar 31, 2018 10-Q 2019-06-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.